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ABSTRACT
Context: Female genital tract cancers are second only to breast malignancies. Cervical cancer is the commonest while 
epithelial cancers constitute the major histologic type. Lymphoid neoplasms are extremely rare, with the Burkitt's 
variety accounting for majority of cases seen in the African female. 
Objective: This is a review of the obstetric/gynaecological patients seen at the University College Hospital, Ibadan 
between 1976 and 2005, predating the commencement of a nationwide research into non – Hodgkin's lymphoma 
funded by the Aboderin Foundation.
Study Design: Records of subjects were analysed for their sociodemographic and clinicopathological characteristics, 
1recruiting only those who satisfy the criteria for diagnosing genital tract lymphomas according to Kosari et al . 
Retrievable archival paraffin blocks of subjects were also analysed using immunophenotyping.
Results: Fifteen cases were identified within the study period; the highest yearly incidence rate being 3 in 1977. In 
eighteen of the years studied no cases were seen. Most cases (80.0%) occurred in the ovaries. Eighty percent (12) of 
patients were 25 years or below and nulliparas and grandmultiparas formed 46.7 and 13.4% respectively. Unilateral or 
bilateral oophorectomy was the commonest surgical procedure (53.3%) while 20.0% had total abdominal 
hysterectomy with or without bilateral salpingoophorectomy. Data were unavailable concerning use of adjuvant 
therapy and outcome of treatment.
Four archival paraffin blocks were available for immunophenotyping using the affordable panel of CD20, CD10 and 
Bcl – 2 antibodies; all were Burkitt's lymphoma.
Conclusion: Female genital lymphomas are very rare, affecting the young and nulliparous. The Burkitt's type is 
commonest.
INTRODUCTION
Malignancies of the female genital tract 
account for 30.6% of cancers in the Nigerian female, 
2
being second only to breast cancer in incidence . 
Worldwide, cancers of the cervix are the most 
common and those of the fallopian tubes have the 
least incidence and prevalence rates amongst 
gynaecological cancers. Epithelial neoplasms are 
the predominant histological types, whereas 
lymphoid neoplasms are extremely rare, being 
among the least common female genital tract 
3malignancies .  
The majority of female genital tract 
lymphomas arise from systemic involvement in 
patients with primarily extragenital lymphomas, and 
only about 1% of primary extranodal lymphomas 
4
originate in the female genital tract . The ovaries and 
adnexa are the most common locations of female 
genital tract lymphomas, followed by the uterus and 
1,3
cervix, vagina and vulva .
About 73% of all previously reported female genital 
3
tract lymphomas are non – Hodgkin's lymphomas . 
1
However, in the series of Kosari et al , less than 1% 
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of all female genital tract lymphomas were due to 
Hodgkin's lymphoma. In African children and 
young adult women, the majority of these cases are 
5,6Burkitt's lymphomas . In a large Caucasian series of 
female genital tract lymphomas, the most common 
morphological variants were diffuse large B cell 
lymphoma, follicular lymphoma and Burkitt's 
1lymphoma, in descending order of frequency .
The diagnosis of genital tract lymphomas is 
hampered by their rarity and the fact that the primary 
sites are usually outside of the pelvis. If not clinically 
7
considered, they can pose a diagnostic challenge . 
The treatment of these lymphomas is usually by 
surgical resection followed by radiotherapy and or 
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chemotherapy. 
The present study is a review of the 
characteristics of patients with genital tract 
lymphomas and their tumours over the thirty year 
period from 1976 to 2005, diagnosed at the 
University College Hospital (UCH), Ibadan, 
Nigeria. This period preceded somewhat the 
nationwide commencement of research into non – 




This is a retrospective study of the case 
records and surgical pathology materials of 
subjects managed at University College Hospital 
(UCH), Ibadan within the thirty year period from 
January 1976 to December 2005. The records of the 
Pathology and Medical Records Departments were 
analysed to extract information about these patients 
and their tumours. These data include their 
sociodemographic and clinicopathological details.
1According to the criteria of Kosari et al , genital 
tract lymphomas recruited in the present study were 
considered as primary only if:
1. The disease process was confined to the 
female genital tract at the time of diagnosis, 
irrespective of involvement of one or more 
genital tract sites.
2. Full investigation did not reveal evidence of 
extragenital lymphoma.
3. The peripheral blood and bone marrow did 
not contain leukemic cells.
4. No remote organs were involved within a 
time lapse of 6 months.
Fresh tissue sections were prepared from all 
available archival paraffin blocks of all eligible 
cases for immunophenotyping of the malignant 
lymphoma subtypes. 
MATERIALS 
The subjects studied were those either managed at 
the various clinical departments in UCH, Ibadan or 
those whose histological specimens were sent to the 
Pathology Department of UCH, Ibadan, for review.
RESULTS
Fifteen cases of gynaecological lymphomas were 
identified between 1976 and 2005, giving an 
estimated incidence rate of 1 case every two years. 
However in eighteen of the thirty years no cases 
were seen while in 1977 and 2000 the highest yearly 
figures of 3 and 2 were seen respectively. 
Time trend and location of cases 
The five yearly trends showed that the highest 
number of cases occurred in the time frame of 1976 to 
1980, while no cases were seen in that of 1991 to 
1995. Most of the cases, 12 (80%) occurred in the 
ovaries, followed by 2 (13.3%) in the pelvic 
retroperitoneal space and 1 (6.7%) in the vagina 
respectively. Table 1 shows these trends. 
Age and parity distribution
Most cases, 12 (80%) occurred in women who were 
25 years or younger, with more than half of these, 7 
(58.3%) aged less than 15 years. The stated parity 
ranged between 0 and 12. Nulliparas constituted half 
of the cases, 7 (46.7%), while the grandmultiparas – 
defined as parity of 5 and above – were 2 (13.3%). 
The parity was not stated in 5 (33.3%) of the cases. 
The age and parity trends are depicted in Table 2. 
MODE OF MANAGEMENT
Unilateral or bilateral oophorectomy was done in 8 
cases (53.3%), while total abdominal hysterectomy 
with or without bilateral salpingoophorectomy was 
carried out in 3 patients (20%). Biopsy of the 
retroperitoneal and vaginal masses was the only 
stated procedure in one case each. In two cases, the 
type of procedure done could not be ascertained. 
Data could not be retrieved about the adjuvant 
therapy instituted or the outcome of treatment in 
terms of survival percentages.
Immunophenotyping
Archival paraffin blocks were available for 
immunophenotyping in only 4 of all 15 (26.7%) 
cases of female genital tract malignant lymphomas. 
All the four were histologically diagnosed as 
Burkitt`s lymphoma of the ovary. Their ages were 10, 
18,  21 and 58 years  respect ively.  The 
immunohistochemical panel of antibodies applied to 
confirm these diagnoses included CD20, CD10 and 
Bcl-2. All cases showed immune-positivity for CD20 
which is consistent with its B – cell lineage and all 
cases also showed immunonegativity for Bcl-2 
which is characteristic of most cases of Burkitt`s 
lymphoma. However only the case seen in the 10 
year old girl showed immunoreactivity with CD10, a 
feature classical of childhood Burkitt`s lymphoma. 
The lack of positivity seen in the older patients is 
remarkable as this pattern suggests that these may be 
cases of adult Burkitt-like lymphoma. Additional 
immunological markers such as CD23, Bcl-6 and 
p53 (which are not presently available at our facility) 
are useful in further differentiation and confirmation 
of these histological subtypes of malignant 
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lymphomas.    
DISCUSSION
Primary malignant lymphomas of the female genital 
tract are very rare diseases which require very 
stringent diagnostic criteria and laboratory facilities 
8, 9, 10
like immunohistochemistry  that are difficult to 
6
obtain in low resource settings . This is compatible 
with our finding of only 15 cases of such malignant 
lymphomas in 30 years at our teaching and referral 
hospital in Ibadan.   
The ovary, like in this study is the commonest site 
8
that is affected . Although diseases limited to the 
vagina and cervix were highlighted in a case series 
11reported by Cohn et al in 2007 , and other parts of 
the female genitalia including the uterus and vulva. 
Apart from the ovary, only two other sites – the 
vagina and the pelvic retroperitoneal space – were 
represented in the patients we studied. 
There is controversy whether indeed these are sites 
of primary tumours or they represent secondaries 
from extra genital lesions. But the demonstration of 
12, 13B and T lymphocytes within the normal ovary  
has been taken as supportive evidence of tumours 
arising primarily from the genitalia, even though 
they are very rare. Primary ovarian lymphoma 
(POL) is thus said to constitute 0.5% of all cases of 
non – Hodgkins lymphomas (NHL) and to occur in 
141.5% of all ovarian malignancies  with the 
commonest type being the diffuse large B-cell 
8lymphoma .
Burkitt's lymphoma of the ovary which was 
confirmed in this study by immunohistochemical 
reactions to CD20, CD10 and Bcl – 2 antibodies by 
all the available archival paraffin blocks is the 
commonest type of ovarian non-Hodgkin's 
lymphoma, as confirmed by a similar study at our 
5centre in 1981 . It is a disease of children and young 
adults. Indeed, eighty per cent of our patients were 
aged 25 years and under. Most were also 
nulliparous. 
9Chishima et al (2006)  described the case of a 25 
year old nulligravida with Burkitt's lymphoma who 
had unilateral salpingoophorectomy and adjuvant 
chemotherapy. She was disease free at the time of 
their reporting, which was 30 months after the initial 
diagnosis. This highlights the possibility that the 
prognosis for ovarian non-Hodgkin's lymphomas is 
14, 15, 16likely to be better than previously thought . 
The implication of all these for practice, apart from 
cure or long term remission is the possibility of 
conservation of fertility when these diseases with 
their predilection for younger women are diagnosed 
early and treated promptly and effectively with 
minimal surgery. It is in this light that the ongoing 
nationwide research efforts into non-Hodgkin's 
lymphomas are being viewed to have the following 
prospects:
1. There will be heightened awareness about the 
diseases. The Ibadan arm of the study for example 
organised workshops involving health care workers 
which sensitized them to develop a higher index of 
suspicion when faced with atypical cases in their 
various areas of medical practice.
2. This will be associated with better screening of 
likely cases through radiological and other 
laboratory investigations and biopsies. 
3. The availability of immunohistochemical means 
to determine immunoreactivity to lymphoma-
specific antigens will ensure more definitive 
diagnoses.
4. The increasing expertise with managing 
gynaecologic oncology cases highlighted by 
17Odukogbe et al  coupled with easier availability of 
chemotherapeutic agents will translate into more 
patients surviving to adulthood and able to retain the 
much desired fertility.  
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Table 2. Age and parity distribution of patients.
Age and parity 
distribution





















16 – 25 years
26 – 35 years












































































Total 7 46.7 1 6.7 2 13.3 5 33.3 15 100
